Patents Assigned to DC EUROPA LIMITED
  • DISCONNECTION AGENTS
    Publication number: 20230341377
    Abstract: The invention relates to the use of disconnection agents before, or together with, toxic agents for the treatment of solid tumours.
    Type: Application
    Filed: September 21, 2021
    Publication date: October 26, 2023
    Applicant: DC Europa Limited
    Inventor: John David GRAINGER
  • AGENT FOR USE IN THE TREATMENT OF GLIOMA
    Publication number: 20220202936
    Abstract: The present invention relates to agents for use in the treatment of glioma, in particular astrocytoma WHO II° and III°, as well as IV° (glioblastoma), in a subject.
    Type: Application
    Filed: January 5, 2022
    Publication date: June 30, 2022
    Applicant: DC EUROPA LIMITED
    Inventors: Matthias Osswald, Wolfgang Wick, Frank Winkler, Erik Jung, Jonas Blaes
  • Agents for use in the treatment of glioma
    Patent number: 11246927
    Abstract: The present invention relates to agents for use in the treatment of glioma, in particular astrocytoma WHO I? and 111°, as well as IV0 (glioblastoma), in a subject.
    Type: Grant
    Filed: July 6, 2016
    Date of Patent: February 15, 2022
    Assignee: DC EUROPA LIMITED
    Inventors: Matthias Osswald, Wolfgang Wick, Frank Winkler, Erik Jung, Jonas Blaes